The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...

In technology advancements, Dexcom's $75 million investment has pushed the valuation of the Finnish health tech company Ōura ...

Dexcom and ŌURA have partnered to integrate Dexcom's glucose biosensing feature with the ŌURA Ring's health metrics to help ...

Smart ring company Oura announced it received $75 million in funding from glucose monitoring and diagnostics company Dexcom.

Dexcom (Nasdaq:DXCM) announced today that it entered into a strategic partnership with Oura, maker of leading smart ring ...

URA, which is now valued at more than $5bn, is set to integrate Dexcom’s glucose capabilities with the Oura ring.

Oura recently introduced its fourth-generation smart ring, but now it’s focusing on a new partnership with another giant in ...

URA has just announced a partnership with Dexcom that will allow the Oura Ring to help monitor your blood sugar.

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.

Smart ring maker Oura Health Oy is getting a $75 million investment from medical device firm Dexcom Inc., setting the stage for the two companies to share data and cross-sell products.

Finland in 2013, makes a smart ring that helps customers track sleep, activity, stress and heart health among other features. Dexcom makes continuous glucose monitoring devices, including a ...

Partnership will enable two-way data flow between Dexcom glucose biosensors and apps and Oura Ring and the Oura App, ...